Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MVP (Bortezomib, Melphalan, Prednisone) in Untreated Multiple Myeloma
NCT00734149Phase 2Completed
- Sponsor
- Duke University
- Start
- Jul 2004
- Primary completion
- Feb 2008
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by Duke University. Started Jul 2004; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00734149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00734149.